Table 2 Univariate analysis of survival by clinicopathologic variables in patients with extrahepatic bile duct carcinoma

From: Clinical and prognostic significances of nuclear and cytoplasmic KIT expressions in extrahepatic bile duct carcinomas

Factor

Characteristics

Number

Median survival (months)

P-value

Sex

Male

145

34

0.46

 

Female

57

27

 

Sizea

2.5b

202

33c

0.18

Growth pattern

Papillary

25

53

0.001*

 

Nodular

17

 
 

Infiltrative

160

29

 

T classification

T1

41

<0.001*

 

T2

65

29

 
 

T3

86

27

 
 

T4

10

13

 

Lymph node metastasis

Present

65

18

<0.001*

 

Absent

137

45

 

Hepatic invasion

Present

11

18

0.23

 

Absent

191

33

 

Pancreatic invasion

Present

84

27

0.03*

 

Absent

118

41

 

Duodenal invasion

Present

10

13

0.003*

 

Absent

192

35

 

Resection marginal status

Positive

44

20

0.04*

 

Negative

158

38

 

Perineural invasion

Present

137

29

0.07

 

Absent

65

50

 

Vascular invasion

Present

48

19

0.002*

 

Absent

154

42

 

KIT expression

Present

49

Not determined

0.01*

 

Absent

153

30

 
  1. aContinuous variable.
  2. bMean.
  3. cMedian survival time at mean.
  4. *Significant at the significance level <0.05.